626 related articles for article (PubMed ID: 31144480)
1. Susceptibility of the Index Urinary Tract Infection to Prophylactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis.
Lee JN; Byeon KH; Woo MJ; Baek HS; Cho MH; Jeong SY; Lee SM; Ham JY; Ha YS; Kim HT; Yoo ES; Kwon TG; Chung SK
J Korean Med Sci; 2019 Jun; 34(21):e156. PubMed ID: 31144480
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Resistance and Urinary Tract Infection Recurrence.
Nelson CP; Hoberman A; Shaikh N; Keren R; Mathews R; Greenfield SP; Mattoo TK; Gotman N; Ivanova A; Moxey-Mims M; Carpenter MA; Chesney RW
Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26969273
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial.
Hari P; Hari S; Sinha A; Kumar R; Kapil A; Pandey RM; Bagga A
Pediatr Nephrol; 2015 Mar; 30(3):479-86. PubMed ID: 25173357
[TBL] [Abstract][Full Text] [Related]
5. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.
Park S; Song SH; Lee C; Kim JW; Kim KS
Urology; 2013 Jun; 81(6):1342-5. PubMed ID: 23562584
[TBL] [Abstract][Full Text] [Related]
6. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
7. Impact of continuous low-dose antibiotic prophylaxis on growth in children with vesicoureteral reflux.
Guidos PJ; Arlen AM; Leong T; Bonnett MA; Cooper CS
J Pediatr Urol; 2018 Aug; 14(4):325.e1-325.e7. PubMed ID: 30181099
[TBL] [Abstract][Full Text] [Related]
8. Renal scarring is the most significant predictor of breakthrough febrile urinary tract infection in patients with simplex and duplex primary vesico-ureteral reflux.
Loukogeorgakis SP; Burnand K; MacDonald A; Wessely K; De Caluwe' D; Rahman N; Farrugia MK
J Pediatr Urol; 2020 Apr; 16(2):189.e1-189.e7. PubMed ID: 31953013
[TBL] [Abstract][Full Text] [Related]
9. The additive impact of the distal ureteral diameter ratio in predicting early breakthrough urinary tract infections in children with vesicoureteral reflux.
Troesch VL; Wald M; Bonnett MA; Storm DW; Lockwood GM; Cooper CS
J Pediatr Urol; 2021 Apr; 17(2):208.e1-208.e5. PubMed ID: 33500223
[TBL] [Abstract][Full Text] [Related]
10. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction.
Herz D; Merguerian P; McQuiston L
J Pediatr Urol; 2014 Aug; 10(4):650-4. PubMed ID: 25155409
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Analysis to Determine the Optimal Timing to Discontinue Continuous Antibiotic Prophylaxis in Patients with Primary Vesicoureteral Reflux.
Anraku T; Obara K; Tasaki M; Tomita Y
Urol Int; 2019; 102(4):462-467. PubMed ID: 30917379
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial prophylaxis for children with vesicoureteral reflux.
; Hoberman A; Greenfield SP; Mattoo TK; Keren R; Mathews R; Pohl HG; Kropp BP; Skoog SJ; Nelson CP; Moxey-Mims M; Chesney RW; Carpenter MA
N Engl J Med; 2014 Jun; 370(25):2367-76. PubMed ID: 24795142
[TBL] [Abstract][Full Text] [Related]
13. Long-term antibiotics for preventing recurrent urinary tract infection in children.
Williams G; Craig JC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167
[TBL] [Abstract][Full Text] [Related]
14. Are prophylactic antibiotics indicated after a urinary tract infection?
Mattoo TK
Curr Opin Pediatr; 2009 Apr; 21(2):203-6. PubMed ID: 19663037
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy.
Alghoraibi H; Asidan A; Aljawaied R; Almukhayzim R; Alsaydan A; Alamer E; Baharoon W; Masuadi E; Al Shukairi A; Layqah L; Baharoon S
J Epidemiol Glob Health; 2023 Jun; 13(2):200-211. PubMed ID: 37273158
[TBL] [Abstract][Full Text] [Related]
16. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
Carpenter MA; Hoberman A; Mattoo TK; Mathews R; Keren R; Chesney RW; Moxey-Mims M; Greenfield SP;
Pediatrics; 2013 Jul; 132(1):e34-45. PubMed ID: 23753091
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
18. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
Mathews R; Mattoo TK
Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
[TBL] [Abstract][Full Text] [Related]
19. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prophylaxis for prevention of urinary tract infections in the first year of life in children with vesicoureteral reflux diagnosed in the workup of antenatal hydronephrosis: a systematic review.
Leigh J; Rickard M; Sanger S; Petropoulos J; Braga LH; Chanchlani R
Pediatr Nephrol; 2020 Sep; 35(9):1639-1646. PubMed ID: 32350666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
